Preliminary study on the effectiveness of low doses of Rituximab in patients with Graves orbitopathy (GO) poorly responding to immunosuppressive steroid treatment.
Phase of Trial: Phase III
Latest Information Update: 01 Jul 2014
At a glance
- Drugs Rituximab (Primary)
- Indications Graves ophthalmopathy
- Focus Registrational; Therapeutic Use
- 01 Jul 2014 New trial record